Despite available data about the beneficial effects of PCSK9 inhibitor antibodies in cardiovascular diseases and hypercholesterolemia, specific data about PCSK9 metabolism and the effects of PCSK9 inhibitors on cardiovascular health in elderly are limited. Here, PCSK9 is linked to familial hypercholesterolemia.